Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumabRyan J Park, Milan Parikh, Leon Pappas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.
American Journal of Respiratory and Critical Care Medicine|December 8, 2021
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19Daniel E Leisman, Arnav Mehta, B Taylor Thompson, et al.
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary InfectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Nature Communications|December 10, 2020
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Pageof 7